Lipum AB (publ) (STO:LIPUM)
Sweden
· Delayed Price · Currency is SEK 14.25
-0.10 (-0.70%)
Mar 9, 2026, 2:31 PM CET
Lipum AB Market Cap
Lipum AB has a market cap or net worth of 304.40 million as of March 9, 2026. Its market cap has decreased by -7.42% in one year.
Market Cap
304.40M
Enterprise Value
302.84M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
14.25
Market Cap Chart
Since April 22, 2021, Lipum AB's market cap has increased from 114.77M to 304.40M, an increase of 165.23%. That is a compound annual growth rate of 22.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 304.40M | -1.71% |
| Dec 30, 2025 | 309.70M | 21.67% |
| Dec 30, 2024 | 254.55M | 319.14% |
| Dec 29, 2023 | 60.73M | -43.12% |
| Dec 30, 2022 | 106.78M | 14.23% |
| Dec 30, 2021 | 93.47M | -18.56% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bio-Works Technologies AB | 315.18M |
| Elicera Therapeutics AB | 315.48M |
| Mendus AB | 258.28M |
| Ascelia Pharma AB | 366.65M |
| Intervacc AB | 229.71M |
| Corline Biomedical AB | 407.26M |
| Xintela AB | 223.93M |
| AlzeCure Pharma AB | 217.76M |